N/A
N=47
Mandibular Overdenture Clinical Trial Comparing Parallel Sided and Tapered Dental Implants
Dental Implants
Bottom Line
View on ClinicalTrials.gov: NCT03272828 ↗Enrolled (actual)
47
Serious AEs
0.0%
Results posted
Jan 2024
Primary outcome: Primary: Difference in Implant Failure Rate Between Parallel Sided and Tapered Dental Implants at 5 Years — 1; 2 Participants — p=0.63
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Nobel Biocare titanium dental implants (Device)
- Age
- Adult, Older Adult · 20+ yrs
- Sex
- All
- Sponsor
- University of Washington
- Primary completion
- Dec 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Difference in Implant Failure Rate Between Parallel Sided and Tapered Dental Implants at 5 Years |
1; 2 | 0.63 |
| SECONDARY Implant Stability Quotient (ISQ) Measured at 5 Years |
80.77; 85.54 | 0.06 |
| SECONDARY Bone Loss Measurement at 5 Years |
1.02; 0.65 | 0.45 |
Summary
The purpose of the study is to compare two different types of dental implants which will be used to support/retain a removable denture in the edentulous mandible. Subjects will have one implant placed in the midline of the mandible after which the patient's existing denture will be modified to fit the implant. The population of this study consists of healthy edentulous individuals 20-75 years of age who have complete dentures in the upper and lower arch.
Eligibility Criteria
Inclusion Criteria
- Be between 20 and 75 years of age
- Be edentulous and have both upper and lower complete dentures
- Present with American Society of Anesthesiologists (ASA) I or ASA II and no medical contraindications to implant treatment
- Have adequate bone volume for placement of one (1) 4.0 mm diameter titanium dental implant with a minimum length of 10 mm in the symphyseal area (=midline) of the anterior mandible
- Show absence of pathology such as cysts, infections in the gum tissue or bone and remaining roots.
- Be able to understand the procedures and have a jaw opening range of 30 mm or more
Exclusion Criteria
- Ongoing chemotherapy
- Previous radiation to head/neck
- Ongoing corticosteroid medication
- Ongoing blood thinner medication
- Ongoing medication with psychopharmacological drugs
- History of alcohol/drug abuse
- Remaining teeth/root tips
- Poor quality /fractured/severely worn dentures that cannot be modified to fit the implant
- Jaw opening range less than 30 mm
Data sourced from ClinicalTrials.gov (NCT03272828). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.